Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00TLD
|
|||
Former ID |
DIB002339
|
|||
Drug Name |
RIG-200
|
|||
Synonyms |
1,3,4,6-Tetra-O-acetyl-2-[2(S)-(acetylamino)-3-methyl-3-(nitrososulfanyl)butyramido]-2-deoxy-beta-D-glucopyranose
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Hypertension [ICD-11: BA00-BA04; ICD-9: 401] | Discontinued in Phase 1 | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C21H31N3O12S
|
|||
Canonical SMILES |
CC(=O)NC(C(=O)NC1C(C(C(OC1OC(=O)C)COC(=O)C)OC(=O)C)OC(=O)C)C(C)(C)SN=O
|
|||
InChI |
1S/C21H31N3O12S/c1-9(25)22-18(21(6,7)37-24-31)19(30)23-15-17(34-12(4)28)16(33-11(3)27)14(8-32-10(2)26)36-20(15)35-13(5)29/h14-18,20H,8H2,1-7H3,(H,22,25)(H,23,30)/t14-,15-,16-,17-,18+,20-/m1/s1
|
|||
InChIKey |
VISYVRBZWPNIOD-GFJCLWMYSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Guanylate cyclase soluble beta-1 (GUCY1B1) | Target Info | Modulator | [2] |
KEGG Pathway | Purine metabolism | |||
cGMP-PKG signaling pathway | ||||
Vascular smooth muscle contraction | ||||
Gap junction | ||||
Platelet activation | ||||
Circadian entrainment | ||||
Long-term depression | ||||
Oxytocin signaling pathway | ||||
Salivary secretion | ||||
NetPath Pathway | TCR Signaling Pathway | |||
IL4 Signaling Pathway | ||||
Panther Pathway | Endothelin signaling pathway | |||
Pathwhiz Pathway | Purine Metabolism | |||
Reactome | Nitric oxide stimulates guanylate cyclase | |||
WikiPathways | Platelet homeostasis |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011948) | |||
REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.